missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
Ristocetin A is structurally related to the glycopeptide antibiotics Teicoplanin and vancomycin. It activates platelets and has been used in platelet aggregation studies.
- Ristocetin-induced platelet agglutination (RIPA) is decreased in patients undergoing chronic hemodialysis
- Together with increased plasma glycocalicin levels (a product of enzymatic cleavage of GPIb), RIPA may contribute to diminished platelet adhesion to vascular subendothelium and increased bleeding associated with uremia
- Addition of ristocetin and vWf caused specific agglutination of rGPIbα-liposomes supporting the potential use of rGPIbα-liposomes to enhance platelet function in vivo and support hemostasis in thrombocytopenic individuals
- Studies have demonstrated that Ristocentin A dimerizes and creates two binding sites for cell wall peptides
Specifications
Specifications
| Physical Form | Powder |
| CAS | 1404-55-3 |
| Quantity | 25 mg |
| Molecular Formula | C95H112N8O48S |
| Synonym | Ristomycin monosulfate |
| Solubility Information | Soluble in 1 N HCl (50mg/mL - clear and colorless to pale yellow); soluble in water (clear 5mg+ 0.25mL, amber solution). |
| InChI Key | HHRPQUHYQBGHHF-ADHWPEJWSA-N |
| SMILES | CC1C(C(CC(O1)OC2C3C(=O)NC(C4=CC(=CC(=C4C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=CC=C2C=C8)OC9C(C(C(C(O9)COC1C(C(C(C(O1)C)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)OC1C(C(C(CO1)O)O)O)OC1=CC=C(C=C1)C(C1C(=O)NC(C2=CC(=C(C(=C2)O)C)OC2=C(C=CC(=C2)C(C(=O)N1)N)O) |
| Molecular Weight (g/mol) | 2166.009 |
| PubChem CID | 46783382 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?